Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting
11 sept. 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
07 sept. 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Global Smoking Cessation & Nicotine De-Addiction Product Market 2023-2028: Featuring Players Pfizer, British American Tobacco, JUUL Labs & GSK PLC
30 août 2023 07h18 HE
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Smoking Cessation & Nicotine De-Addiction Product Market (2023-2028) by Product, Distribution Channel, and Geography, Competitive Analysis,...
Well-Being Platform Market Size to Reach $712.20 Billion, Globally, by 2030 at 5.9% CAGR with Fitness Segment Driving Growth During 2022-2030 | The Insight Partners
10 août 2023 10h07 HE
|
The Insight Partners
Pune, India, Aug. 10, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on “Well-Being Platform Market Size Report & Share, Forecast to 2030 – COVID-19 Impact and Global...
Corporate Wellness Market predicted to exceed US$ 138 billion by 2031, rising at a CAGR of 8.4%: TMR Research
08 août 2023 08h10 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The global market for corporate wellness was estimated to have garnered a global market valuation of around US$ 66.5 billion in...
Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast
01 août 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting
18 juil. 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, July 18, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)
11 juil. 2023 11h23 HE
|
Achieve Life Sciences
Cytisinicline 6- and 12-week dosing schedules, with behavioral support, demonstrated “smoking cessation efficacy and excellent tolerability” Supports potential for cytisinicline to be the first...
Growth Report: Digital Therapeutics Market Worth $18 Billion, Globally, by 2028 at 23.1% CAGR | The Insight Partners
21 juin 2023 10h26 HE
|
The Insight Partners
Pune, India, June 21, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Digital Therapeutics Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Application, and...
New solutions urgently needed to tackle smoking worldwide: experts to convene in Poland at the Global Forum on Nicotine
19 juin 2023 10h17 HE
|
Global Forum on Nicotine
WARSAW, Poland, June 19, 2023 (GLOBE NEWSWIRE) -- International public health specialists, scientists, doctors, regulators, consumers and manufacturers are convening this week in the Polish capital...